ARCHIVES

RFA On Promoters, Hormones, Other Cofactors Available

This article is from The Cancer Letter archive.

Vol. 07 No. 29 | July 17, 1981

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: President’s Cancer Panel Issues Statement On National Cancer Program

September 17, 1999

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

Clinical Trials Approved By NCI CTEP Last Month

March 25, 2011

Adjuvant Nutrition Breast Cancer Study Offered To Groups

March 19, 1982